History
  • No items yet
midpage
Perfect Surgical Techniques, Inc. v. Olympus America, Inc.
841 F.3d 1004
Fed. Cir.
2016
Read the full case

Background

  • PST appealed the PTAB’s IPR decision that JP ’551 anticipated or rendered obvious multiple claims of U.S. Patent No. 6,030,384; the Board treated JP ’551 as prior art under pre-AIA §102(a).
  • Olympus submitted JP ’551 with a partial English translation missing the bibliographic page; Board accepted it and found publication date Feb. 10, 1998; PST argued the missing translation was fatal.
  • PST sought to antedate JP ’551 under pre-AIA §102(g) by proving earlier conception and reasonable diligence in reduction to practice by inventor Dr. Camran Nezhat during the critical period (Feb. 9–May 1, 1998).
  • Record: draft sent to Nezhat Jan 28, 1998; Nezhat returned comments Mar 2; Heslin (attorney) sent questions Mar 12 and met Mar 16; Heslin revised Apr 7, sent second draft Apr 13, and filed application May 1. PST introduced declarations, letters, and billing records to corroborate diligence.
  • The Board found unexplained gaps (Feb 10–Mar 1; Mar 12–15; Apr 13–May 1), concluded PST failed to show continuous diligence, and held claims invalid over JP ’551. PST appealed claim construction and diligence findings.

Issues

Issue Plaintiff's Argument (PST) Defendant's Argument (Olympus / Board) Held
1. Validity of relying on a partly untranslated JP ’551 Olympus’s partial translation was defective because bibliographic page (publication date) wasn’t translated Translator certification plus discernible date on untranslated page sufficed; date was not disputed Court: Board’s acceptance was harmless error (translator certified pub. date; PST didn’t dispute date) — acceptance stands
2. Whether PST antedated JP ’551 by proving reasonable diligence (critical period Feb 9–May 1, 1998) Nezhat and Heslin provided testimony, letters, billing records showing ongoing work; diligence should be judged under a "rule of reason" requiring reasonably continuous (not literally continuous) diligence Board identified specific unexplained gaps and found lack of "continuous exercise of reasonable diligence;" attorney activity insufficiently credited for some gaps Court: Board applied an impermissibly exacting standard and failed to apply rule-of-reason / weigh attorney’s activities; vacated & remanded for reconsideration of diligence on whole record
3. Whether the Board erred by disregarding attorney Heslin’s activities as imputable to inventor Attorney’s work preparing and filing the application is imputable and should be considered as corroboration of inventor’s diligence Board downplayed Heslin’s work and declined to rely on it to fill gaps Court: Board erred by not properly crediting Heslin’s activity; on remand must consider attorney’s testimony and billing as part of diligence analysis
4. Proper claim construction of term "perforated" in claims (affects anticipation by JP ’551) "Perforated" should be limited as distinct from "passages" because specification uses "perforated or otherwise provided with passages" Board construed "perforated" broadly to include "passages" and found JP ’551 discloses perforations Court: Specification distinguishes perforations from passages; "perforated" does not encompass passages — vacated invalidity of claims 11, 38, 41–44, 46, 47, 49 and remanded for proceedings consistent with this construction

Key Cases Cited

  • Monsanto Co. v. Mycogen Plant Sci., Inc., 261 F.3d 1356 (Fed. Cir. 2001) (diligence must be shown throughout the critical period; rule-of-reason analysis)
  • Brown v. Barbacid, 436 F.3d 1376 (Fed. Cir. 2006) (corroboration requirement; variety of activities may corroborate diligence)
  • In re Steed, 802 F.3d 1311 (Fed. Cir. 2015) (antedating is legal question based on subsidiary facts; review standard)
  • In re Cuozzo Speed Techs., LLC, 793 F.3d 1268 (Fed. Cir. 2015) (Board applies broadest reasonable interpretation in IPRs)
  • Teva Pharm. USA, Inc. v. Sandoz, Inc., 135 S. Ct. 831 (U.S. 2015) (factual subsidiary findings in claim construction reviewed for substantial evidence)
  • Thorner v. Sony Comput. Entm’t Am. LLC, 669 F.3d 1362 (Fed. Cir. 2012) (patentee may act as lexicographer; specification can limit claim terms)
  • In re Mulder, 716 F.2d 1542 (Fed. Cir. 1983) (short unexplained inactivity can defeat diligence when critical period is very short)
  • In re Jolley, 308 F.3d 1317 (Fed. Cir. 2002) (corroboration may be circumstantial; not every factual issue requires direct corroboration)
  • Creative Compounds, LLC v. Starmark Labs., 651 F.3d 1303 (Fed. Cir. 2011) (applicant must account for the entire period during which diligence is required)
  • Mahurkar v. C.R. Bard, Inc., 79 F.3d 1572 (Fed. Cir. 1996) (conception plus diligent reduction to practice required to antedate)
  • Gould v. Schawlow, 363 F.2d 908 (C.C.P.A. 1966) (inventor must provide specific dates and facts to account for entire period)
  • In re McIntosh, 230 F.2d 615 (C.C.P.A. 1956) (formulation of diligence as "continuous exercise of reasonable diligence")
Read the full case

Case Details

Case Name: Perfect Surgical Techniques, Inc. v. Olympus America, Inc.
Court Name: Court of Appeals for the Federal Circuit
Date Published: Nov 15, 2016
Citation: 841 F.3d 1004
Docket Number: 2015-2043
Court Abbreviation: Fed. Cir.